Citation Impact
Citing Papers
B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
2010
Serum Biomarker Panels for the Detection of Pancreatic Cancer
2011
Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression
2013 StandoutNobel
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
2005 Standout
CD4+ Tregs and immune control
2004 StandoutNobel
B7-1/2 (CD80/CD86) Direct Signaling to B Cells Enhances IgG Secretion
2009
Constitutive Expression of IDO by Dendritic Cells of Mesenteric Lymph Nodes: Functional Involvement of the CTLA-4/B7 and CCL22/CCR4 Interactions
2009 StandoutNobel
Mechanisms of action of tasquinimod on the tumour microenvironment
2013
Designing and developing a literature-derived, population-based dietary inflammatory index
2013 Standout
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
FOXP3+ regulatory T cells: control of FOXP3 expression by pharmacological agents
2011 StandoutNobel
Rheumatoid arthritis
2016 Standout
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Regulatory T cells exert checks and balances on self tolerance and autoimmunity
2009 StandoutNobel
Ribosome-inactivating proteins from plants
1993
Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
2012
Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control
2015
CTLA-4: new insights into its biological function and use in tumor immunotherapy
2002 StandoutNobel
Type I interferons in infectious disease
2015 Standout
Purinergic regulation of the immune system
2016
Immunogenic cell death in cancer and infectious disease
2016 Standout
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
2011 StandoutNobel
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
2003 Standout
Control of Germinal Center Responses by T-Follicular Regulatory Cells
2018 StandoutNobel
Regulatory T cells mediate maternal tolerance to the fetus
2004 Standout
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors
2004
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Structural mechanisms of costimulation
2002
Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer
2007
CD86 and β2-Adrenergic Receptor Signaling Pathways, Respectively, Increase Oct-2 and OCA-B Expression and Binding to the 3′-IgH Enhancer in B Cells
2004
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4
2014 StandoutNobel
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Multiple treg suppressive modules and their adaptability
2012 StandoutNobel
Checkpoint Blockade in Cancer Immunotherapy
2006 StandoutNobel
BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1
2003 StandoutNobel
CTLA-4–Ig regulates tryptophan catabolism in vivo
2002
Dynamics of peripheral tolerance and immune regulation mediated by Treg
2009 StandoutNobel
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse
2004 StandoutNobel
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Immune Modulation in Cancer with Antibodies
2013 StandoutNobel
Different cell surface oligomeric states of B7-1 and B7-2: Implications for signaling
2005
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma
2005
THE B7 FAMILY REVISITED
2005 Standout
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors
2008 StandoutNobel
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Molecular Modeling and Functional Mapping of B7-H1 and B7-DC Uncouple Costimulatory Function from PD-1 Interaction
2003 StandoutNobel
Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood
2016 StandoutNobel
CD4+ Tregs and immune control
2004 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
CTLA-4 Overexpression Inhibits T Cell Responses through a CD28-B7-Dependent Mechanism
2006 StandoutNobel
PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells
2003 StandoutNobel
Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling
2003
Selective Regulation of Mature IgG1 Transcription by CD86 and β2-Adrenergic Receptor Stimulation
2003
Tolerogenic Dendritic Cells
2003 StandoutNobel
Women Empowerment and Economic Development
2012 StandoutNobel
Soil Endowments, Female Labor Force Participation, and the Demographic Deficit of Women in India
2014
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4
2013 StandoutNobel
B Cell-Specific Expression of B7-2 Is Required for Follicular Th Cell Function in Response to Vaccinia Virus
2011
Engineering Chemical Reactivity on Cell Surfaces Through Oligosaccharide Biosynthesis
1997 StandoutScienceNobel
Works of Vinod Singh being referenced
Inflammation, Microenvironment, and the Immune System in Cancer Progression
2009
Distinct Role of CD80 and CD86 in the Regulation of the Activation of B Cell and B Cell Lymphoma
2002
Hormonotoxins: conjugation of human choriogonadotropin with the ribosome inactivating protein gelonin and comparison with a lutropin conjugate
1989
Melanoma Progression Despite Infiltration by In Vivo-primed TRP-2–specific T Cells
2009
Demographic Zones in India
1994